Issue Archive

Consultant for Pediatricians

Research Summaries

Research Summary

Research Summary

Obexelimab Reduced IgG4-Related Disease Flares vs Placebo in Phase 3 Trial

06/24/2026

Anthony Calabro, MA

In a phase 3 randomized controlled trial of adults with active IgG4-related disease, weekly subcutaneous obexelimab significantly prolonged time to first flare requiring rescue therapy vs placebo and...

06/24/2026

FDA Approval

FDA Approval

Ensitrelvir (Xocova) Receives FDA Approval for COVID-19 Post-Exposure Prophylaxis

06/23/2026

Anthony Calabro, MA

The FDA approved ensitrelvir (Xocova) for post-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older following contact with an individual with COVID-19.

06/23/2026

FDA Approval

FDA Approval

FDA Approves Utebzi as First Oral Carbapenem Therapy for Complicated Urinary Tract Infections in Adults

06/23/2026

The FDA approved tebipenem pivoxil (Utebzi) for adults with complicated urinary tract infections, including pyelonephritis, who have limited or no alternative oral treatment options.

06/23/2026

Conference Coverage

Conference Coverage

Conference Preview: Migraine and Headache Sessions Address Primary Care, Veterans, Emergency Care, and Status Migraine

06/22/2026

Anthony Calabro, MA

Several sessions at the 2026 American Association of Nurse Practitioners National Conference in Las Vegas, NV, will address migraine-related diagnosis, treatment, red flags, and care considerations across...

06/22/2026

Research Summary